Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Roche picks up European rights to diabetes implant

Will distribute Senseonics' Eversense CGM System in Germany, Italy and the Netherlands

Roche Eversense CGM Senseonics 

Roche's diabetes business has acquired distribution rights to an implantable long-term continuous glucose monitoring (CGM) system.

It will commercialise Senseonics' Eversense CGM system, selling the implant to diabetes patients and clinics in Germany, Italy and the Netherlands, with an options to expand the deal to further countries and products in the future.

The Eversense combines a small sensor that works for us to 90 days, a wearable and removable smart transmitter and mobile application, and seeks to replace the weekly CGM systems currently on the market.

The Eversense sensor is inserted below the patient's skin and uses flurorescence sensing technology to communicate with the smart transmitter, which then wirelessly sends blood glucose levels to the mobile app.

Tim Goodnow, CEO and president of Senseonics, said: “Together with Roche's market presence, and extensive sales and support network, we aim to deliver a truly innovative continuous, long-term glucose monitoring solution to millions of people with diabetes.”

Goodnow's company will retain responsibility for product development, regulatory approval, quality management, and manufacturing while Roche will take on sales, marketing, customer support and distribution activities in the agreement's territories.

The Maryland, US-based medical technology company's deal with Roche follows its agreement with Rubin Medical, which has the rights to market the Eversense system in Sweden, and follows soon after a tie-up between Medtronic and Qualcomm for a new range of diabetes sensors.

Meanwhile, Senseonics last month won a European Kitemark for the Eversense system, confirming it meets the European Commission's Essential Requirements of the Active Implantable Medical Device Directive.

2nd June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...

Infographics